SCHEMBL13954643

SCHEMBL13954643

Cc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cc(F)ccc3N3CCN(C(=O)OC(C)(C)C)CC3)cs1)C2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 11/20 0.65
JAK2 O60674 1/20 0.51
ROCK2 O75116 1/20 0.51
IGF1R P08069 1/20 0.51
MAPK1 P28482 1/20 0.51
AKT1 P31749 1/20 0.51
RPS6KA3 P51812 1/20 0.51
NEK2 P51955 1/20 0.51
STK3 Q13188 1/20 0.51
CAMK4 Q16566 1/20 0.51
TSSK2 Q96PF2 1/20 0.51
IRAK4 Q9NWZ3 1/20 0.51
BACE1 P56817 6/20 0.44
GPR6 P46095 1/20 0.39
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13156340 0.92 CHEK1 (0.78) CHEK1JAK2ROCK2IGF1RMAPK1
SCHEMBL13323359 0.89 CHEK1 (0.74) CHEK1JAK2ROCK2IGF1RMAPK1
SCHEMBL13322864 0.80 CHEK1 (0.78) CHEK1JAK2ROCK2IGF1RMAPK1
SCHEMBL13156293 0.80 BACE1 (0.58) CHEK1IRAK4BACE1GPR6MAPT
SCHEMBL13156316 0.79 BACE1 (0.48) CHEK1IRAK4BACE1GPR6
SCHEMBL13156341 0.79 CHEK1 (1.00) CHEK1JAK2ROCK2IGF1RMAPK1
SCHEMBL14038926 0.78 CHEK1 (0.81) CHEK1JAK2ROCK2IGF1RMAPK1
SCHEMBL13156307 0.78 CHEK1 (0.74) CHEK1JAK2ROCK2IGF1RMAPK1
SCHEMBL13156342 0.78 CHEK1 (0.62) CHEK1JAK2ROCK2IGF1RMAPK1
SCHEMBL13156308 0.77 BACE1 (0.49) CHEK1BACE1GPR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017701-A2 ANTI-MITOTIC AGENT AND AURORA KINASE INHIBITOR COMBINATION AS ANTI-CANCER TREATMENT SCHERING CORPORATION (US) 2009-02-05 WO disclosed